Gemma Logan

Discover how Almac Diagnostic Services, as a speciality CRO, has created a connected specimen-to-data ecosystem that protects biomarker integrity across global clinical trials. Using practical examples, this session explores how harmonised sample operations, integrated pathology and biorepository services, and in-life testing, including multi-omics approaches, such as NGS & IHC, can generate trusted, decision-ready data that helps inform and strengthen biomarker strategy. The presentation will highlight how to avoid common pitfalls and create operational efficiencies, quality governance, and a scalable solution required for todays’ complex clinical trials.

• How Almac’s integrated speciality CRO model can strengthen tissue stewardship, traceability, quality and operational resilience
• Practical strategies for designing a global, harmonized specimen lifecycle from site collection to biomarker data delivery
• How to embed in-life testing and multi-omics into clinical trial protocols to deliver earlier, actionable insight